An in vitro study on the combination effect of metformin and n-acetyl cysteine against hyperglycaemia-induced cardiac damage
dc.contributor.author | Mabhida, Sihle E. | |
dc.date.accessioned | 2022-12-05T10:55:54Z | |
dc.date.available | 2022-12-05T10:55:54Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Chronic hyperglycaemia is a major risk factor for diabetes-induced cardiovascular dysfunction. In a hyperglycaemic state, excess production of reactive oxygen species (ROS), coupled with decreased levels of glutathione, contribute to increased lipid peroxidation and subsequent myocardial apoptosis. N-acetylcysteine (NAC) is a thiol-containing antioxidant known to protect against hyperglycaemic-induced oxidative stress by promoting the production of glutathione | en_US |
dc.identifier.citation | Johnson, Rabia, Nonhlakanipho F. Sangweni, Sihle E. Mabhida, Phiwayinkosi V. Dludla, Lawrence Mabasa, Sylvia Riedel, Charna Chapman, Rebamang A. Mosa, Abidemi P. Kappo, Johan Louw, and Christo J. F. Muller. 2019. "An In Vitro Study on the Combination Effect of Metformin and N-Acetyl Cysteine against Hyperglycaemia-Induced Cardiac Damage" Nutrients 11, no. 12: 2850. https://doi.org/10.3390/nu11122850 | en_US |
dc.identifier.issn | 2072-6643 | |
dc.identifier.uri | http://hdl.handle.net/10566/8234 | |
dc.language.iso | en_US | en_US |
dc.publisher | MDPI - Publisher of Open Access Journals | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | diabetes | en_US |
dc.subject | apoptosis | en_US |
dc.subject | N-acetyl cysteine | en_US |
dc.subject | metformin | en_US |
dc.title | An in vitro study on the combination effect of metformin and n-acetyl cysteine against hyperglycaemia-induced cardiac damage | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- mabhida_metformin_n-acetyl-cysteine_2019.pdf
- Size:
- 3.61 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: